Literature DB >> 17258708

p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury.

Ji-Tian Xu1, Wen-Jun Xin, Xu-Hong Wei, Chang-You Wu, Yu-Xing Ge, Yan-Ling Liu, Ying Zang, Tong Zhang, Yong-Yong Li, Xian-Guo Liu.   

Abstract

Compelling evidence shows that the adjacent uninjured primary afferents play an important role in the development of neuropathic pain after nerve injury. The underlying mechanisms, however, are largely unknown. In the present study, the selective motor fiber injury was performed by L5 ventral root transection (L5 VRT), and p38 activation in dorsal root ganglia (DRG) and L5 spinal dorsal horn was examined. The results showed that phospho-p38 immunoreactivity (p-p38-IR) was increased in both L4 and L5 DRGs, starting on day 1 and persisting for nearly 3 weeks (P<0.05) following L5 VRT and that the activated p38 was confined in neurons, especially in IB4 positive C-type neurons. L5 VRT also induced p38 activation in L5 spinal dorsal horn, occurred at the first day after the lesion and lasted for 2 weeks (P<0.05). The activated p38 is restricted entirely in spinal microglia. In contrast, selective injury of sensory neurons by L5 dorsal root transection (L5 DRT) failed to induce behavioral signs of neuropathic pain and activated p38 only in L5 DRG but not in L4 DRG and L5 spinal dorsal horn. Intraperitoneal injection of thalidomide, an inhibitor of TNF-alpha synthesis, prevented p38 activation in DRG and spinal cord. Intrathecal injection of p38 inhibitor SB203580, starting before L5 VRT, inhibited the abnormal pain behaviors. Post-treatment with SB203580 performed at the 1st day or at the 8th day after surgery also reduced established neuropathic pain. These data suggest that p38 activation in uninjured DRGs neurons and in spinal microglia is necessary for the initiation and maintenance of neuropathic pain induced by L5 VRT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17258708     DOI: 10.1016/j.expneurol.2006.11.016

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  40 in total

1.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

2.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 3.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

Review 4.  Intracellular signaling in primary sensory neurons and persistent pain.

Authors:  Jen-Kun Cheng; Ru-Rong Ji
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

5.  Electroacupuncture attenuates spinal nerve ligation-induced microglial activation mediated by p38 mitogen-activated protein kinase.

Authors:  Yi Liang; Jun-Ying Du; Yu-Jie Qiu; Jun-Fan Fang; Jin Liu; Jian-Qiao Fang
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

Review 6.  Emerging role of Toll-like receptors in the control of pain and itch.

Authors:  Tong Liu; Yong-Jing Gao; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2012-04       Impact factor: 5.203

7.  R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids.

Authors:  Philipp Bishay; Helmut Schmidt; Claudiu Marian; Annett Häussler; Nina Wijnvoord; Simone Ziebell; Julia Metzner; Marco Koch; Thekla Myrczek; Ingo Bechmann; Rohini Kuner; Michael Costigan; Faramarz Dehghani; Gerd Geisslinger; Irmgard Tegeder
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

8.  Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy.

Authors:  Munmun Chattopadhyay; Marina Mata; David J Fink
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

9.  Novel Therapeutic Targets in Neuroinflammation and Neuropathic Pain.

Authors:  Geeta Ramesh
Journal:  Inflamm Cell Signal       Date:  2014

10.  Attenuation of neuropathic pain by saikosaponin a in a rat model of chronic constriction injury.

Authors:  Xin Zhou; Hong Cheng; Dedong Xu; Qing Yin; Lei Cheng; Lei Wang; Shasha Song; Mengyuan Zhang
Journal:  Neurochem Res       Date:  2014-08-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.